...
首页> 外文期刊>Journal of cataract and refractive surgery >Three year results of photoastigmatic refractive keratectomy for mild and atypical keratoconus.
【24h】

Three year results of photoastigmatic refractive keratectomy for mild and atypical keratoconus.

机译:温和和非典型角蛋白的光纤屈光屈光术术的三年结果。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: To evaluate the long-term effect of photoastigmatic refractive keratectomy (PARK) on mild keratoconus. SETTING: Laser Unit, Ein Tal Eye Center, Tel Aviv, Israel. METHODS: Eight eyes of 6 patients with stable compound myopic astigmatism and topography features of keratoconus were treated with a VISX Twenty-Twenty excimer laser. The laser beam slit width ranged between 4.8 and 5.0 mm according to the degree of cylinder. Preoperative slitlamp examination did not reveal significant thinning, ectasia, or scarring. Astigmatism ranged between -2.00 and -7.50 diopters and follow-up, between 36 and 48 months. RESULTS: In 7 of 8 eyes, uncorrected visual acuity (UCVA) before PARK ranged between 6/30 and finger counting. After PARK, it ranged between 6/9(-) and 6/15, and patients could manage in most of their daily activities without using spectacles. In 2 eyes, the final UCVA was 6/15(-) and 6/15. In 1 eye, treatment failed to improve UCVA and corneal topography revealed progression of the keratoconus. CONCLUSIONS: Photoastigmatic keratectomy was partially effective in eyes with mild stable keratoconus. However, the long-term results may be altered by progression of corneal thinning and ecstatic disease. In addition to the mild nature of the keratoconus, this is a small series and further studies are needed to confirm these results.
机译:目的:评估光倒像屈光角膜切除术(PARK)对轻度角蛋白的长期效果。设置:激光单元,Ein Tey Center,特拉维夫,以色列。方法:用VISX二十二十分子激光治疗6例稳定复方近二十二十二十二十次准分激光治疗KeratoConus稳定复方近视散光和形貌特征的八个眼睛。根据圆柱的程度,激光束狭缝宽度范围在4.8和5.0mm之间。术前粘液检查未显示出显着的稀疏,异位或瘢痕形成。散光在-2.00和-7.50折线之间,36到48个月之间。结果:在8只眼睛的7个中,Park在6/30和手指计数之间的不规则的视力(UCVA)。停车后,它在6/9( - )和6月15日之间,患者可以在大多数日常活动中管理而不使用眼镜。在2只眼中,最终UCVA是6/15( - )和6/15。在1只眼睛中,治疗未能提高UCVA和角膜地形揭示了角蛋白酶的进展。结论:光摩托型角膜切除术在用轻度稳定角蛋白酶的眼中部分有效。然而,长期结果可以通过角膜稀释和狂喜疾病的进展来改变。除了角蛋白的温和性,这是一个小系列,需要进一步研究来确认这些结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号